Skip to main content
logo
Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
38.37
-0.53 (-1.36%)
Jan 2, 2026, 11:50 AM EST - Market open

Castle Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
1,1207465816201,1031,622
Upgrade
Market Cap Growth
38.51%28.53%-6.38%-43.76%-32.00%176.41%
Upgrade
Enterprise Value
8854933663687401,461
Upgrade
Last Close Price
38.9026.6521.5823.5442.8767.15
Upgrade
PE Ratio
-40.91----
Upgrade
PS Ratio
3.252.252.644.5311.7225.89
Upgrade
PB Ratio
2.431.641.481.552.683.90
Upgrade
P/TBV Ratio
3.112.132.122.273.423.90
Upgrade
P/FCF Ratio
44.7420.43---317.18
Upgrade
P/OCF Ratio
18.3811.51---164.43
Upgrade
EV/Sales Ratio
2.581.491.662.697.8623.33
Upgrade
EV/EBITDA Ratio
113.0520.00----
Upgrade
EV/EBIT Ratio
-56.90----
Upgrade
EV/FCF Ratio
34.8813.50---285.78
Upgrade
Debt / Equity Ratio
0.080.060.040.030.02-
Upgrade
Debt / EBITDA Ratio
3.400.96----
Upgrade
Debt / FCF Ratio
1.460.72----
Upgrade
Asset Turnover
0.640.680.490.300.210.22
Upgrade
Inventory Turnover
9.057.497.5510.677.475.61
Upgrade
Quick Ratio
6.126.975.907.8113.9420.24
Upgrade
Current Ratio
6.477.296.208.0914.2220.58
Upgrade
Return on Equity (ROE)
-2.70%4.31%-14.54%-16.56%-7.56%-4.11%
Upgrade
Return on Assets (ROA)
-1.72%1.10%-9.43%-12.52%-5.56%-1.88%
Upgrade
Return on Capital (ROIC)
-1.91%1.22%-10.37%-13.68%-6.00%-2.00%
Upgrade
Return on Capital Employed (ROCE)
-2.90%1.80%-16.80%-22.20%-9.20%-2.00%
Upgrade
Earnings Yield
-1.08%2.44%-9.89%-10.82%-2.84%-0.63%
Upgrade
FCF Yield
2.23%4.90%-3.31%-7.62%-2.04%0.32%
Upgrade
Buyback Yield / Dilution
-1.04%-9.15%-2.87%-3.65%-32.80%-118.63%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q